Results From the DoPING-HFpEF Trial: A Double Blind, Placebo-Controlled Randomized Cross-Over Trial Investigating Trimetazidine in Heart Failure With Preserved Ejection Fraction

被引：0
|
作者：
de Bovenkamp, Arno A. Van
Bakermans, Adrianus J. J.
Geurkink, Kiki J.
Oosterveer, Frank T.
De Man, Frances S.
Kok, Wouter E.
Nederveen, Aart J.
van Rossum, Albert C.
Handoko, M. Louis L.
机构：
来源：
CIRCULATION | 2022年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A12368
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Trimetazidine in heart failure with preserved ejection fraction: a randomized controlled cross-over trial
    van de Bovenkamp, Arno A.
    Geurkink, Kiki T. J.
    Oosterveer, Frank T. P.
    de Man, Frances S.
    Kok, Wouter E. M.
    Bronzwaer, Patrick N. A.
    Allaart, Cor P.
    Nederveen, Aart J.
    van Rossum, Albert C.
    Bakermans, Adrianus J.
    Handoko, M. Louis
    ESC HEART FAILURE, 2023, 10 (05): : 2998 - 3010
  • [2] TrimetaziDine as a Performance-enhancING drug in heart failure with preserved ejection fraction (DoPING-HFpEF): rationale and design of a placebo-controlled cross-over intervention study
    van de Bovenkamp, A. A.
    Bakermans, A. J.
    Allaart, C. P.
    Nederveen, A. J.
    Kok, W. E. M.
    van Rossum, A. C.
    Handoko, M. L.
    NETHERLANDS HEART JOURNAL, 2020, 28 (06) : 312 - 319
  • [3] TrimetaziDine as a Performance-enhancING drug in heart failure with preserved ejection fraction (DoPING-HFpEF): rationale and design of a placebo-controlled cross-over intervention study
    A. A. van de Bovenkamp
    A. J. Bakermans
    C. P. Allaart
    A. J. Nederveen
    W. E. M. Kok
    A. C. van Rossum
    M. L. Handoko
    Netherlands Heart Journal, 2020, 28 : 312 - 319
  • [4] TrimetaziDine as a Performance-enhancING drug in Heart Failure with Preserved Ejection Fraction (DoPING-HFpEF): Rationale and design of a placebo-controlled cross-over intervention study.
    Van De Bovenkamp, A. A.
    Bakermans, A. J.
    Allaart, C. P.
    Nederveen, A. J.
    Kok, W. E. M.
    Van Rossum, A. C.
    Handoko, M. L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 357 - 357
  • [5] Trimetazidine in heart failure with preserved ejection fracton: a randomized, double-blind cross-over trial
    Van De Bovenkamp, A. A.
    Bakermans, A. J.
    Geurkink, K. J. T.
    Oosterveer, F. T. P.
    De Man, F. S.
    De Kok, W. E. M.
    Nederveen, A. J.
    Van Rossum, A. C.
    Handoko, M. L.
    EUROPEAN HEART JOURNAL, 2022, 43 : 776 - 776
  • [6] Coenzyme Q10 in the Treatment of Heart Failure with Preserved Ejection Fraction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
    Tal Y. Samuel
    Tal Hasin
    Israel Gotsman
    Tanya Weitzman
    Fanny Ben Ivgi
    Ziv Dadon
    Elad Asher
    Offer Amir
    Michael Glikson
    Ronny Alcalai
    David Leibowitz
    Drugs in R&D, 2022, 22 : 25 - 33
  • [7] Coenzyme Q10 in the Treatment of Heart Failure with Preserved Ejection Fraction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
    Samuel, Tal Y.
    Hasin, Tal
    Gotsman, Israel
    Weitzman, Tanya
    Ben Ivgi, Fanny
    Dadon, Ziv
    Asher, Elad
    Amir, Offer
    Glikson, Michael
    Alcalai, Ronny
    Leibowitz, David
    DRUGS IN R&D, 2022, 22 (01) : 25 - 33
  • [8] The effect of Aliskiren on exercise capacity in older patients with heart failure and preserved ejection fraction: A randomized, placebo-controlled, double-blind trial
    Upadhya, Bharathi
    Brubaker, Peter H.
    Morgan, Timothy M.
    Eggebeen, Joel D.
    Jao, Geoffrey T.
    Stewart, Kathryn P.
    Kitzman, Dalane W.
    AMERICAN HEART JOURNAL, 2018, 201 : 164 - 167
  • [9] Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial
    Komajda, Michel
    Isnard, Richard
    Cohen-Solal, Alain
    Metra, Marco
    Pieske, Burkert
    Ponikowski, Piotr
    Voors, Adriaan A.
    Dominjon, Fabienne
    Henon-Goburdhun, Cecile
    Pannaux, Matthieu
    Bohm, Michael
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (11) : 1495 - 1503
  • [10] Double-blind, randomized, placebo-controlled, cross-over trial of pregabalin in essential tremor
    Ferrara, J. M.
    Kenney, C.
    Davidson, A. L.
    Shinawi, L.
    Kissel, A. M.
    Jankovic, J.
    MOVEMENT DISORDERS, 2009, 24 : S508 - S508
12345